Vagal Blocking Improves Glycemic Control and Elevated Blood Pressure in Obese Subjects with Type 2 Diabetes Mellitus
Open Access
- 30 July 2013
- journal article
- clinical trial
- Published by Hindawi Limited in Journal of Obesity
- Vol. 2013, 1-8
- https://doi.org/10.1155/2013/245683
Abstract
Background. An active device that downregulates abdominal vagal signalling has resulted in significant weight loss in feasibility studies.Objective. To prospectively evaluate the effect of intermittent vagal blocking (VBLOC) on weight loss, glycemic control, and blood pressure (BP) in obese subjects with DM2.Methods. Twenty-eight subjects were implanted with a VBLOC device (Maestro Rechargeable System) at 5 centers in an open-label study. Effects on weight loss, HbA1c, fasting blood glucose, and BP were evaluated at 1 week to 12 months.Results. 26 subjects (17 females/9 males,years, BMI kg/m2, mean ± SEM) completed 12 months followup. One serious adverse event (pain at implant site) was easily resolved. At 1 week and 12 months, mean excess weight loss percentages (% EWL) were% and% (), and HbA1cdeclined by% and% (, baseline%). In DM2 subjects with elevated BP (), mean arterial pressure reduced by mmHg and mmHg (, baseline mmHg) at 1 week and 12 months. All subjects MAP decreased by mmHg (baseline mmHg) at 12 months.Conclusions. VBLOC was safe in obese DM2 subjects and associated with meaningful weight loss, early and sustained improvements in HbA1c, and reductions in BP in hypertensive DM2 subjects. This trial is registered with ClinicalTrials.govNCT00555958.
Keywords
This publication has 27 references indexed in Scilit:
- Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with DiabetesNew England Journal of Medicine, 2012
- An Afferent Vagal Nerve Pathway Links Hepatic PPARα Activation to Glucocorticoid-Induced Insulin Resistance and HypertensionCell Metabolism, 2007
- Recommendations for Blood Pressure Measurement in Humans and Experimental AnimalsCell Metabolism, 2005
- The Enteroinsular Axis and the Recovery from Type 2 Diabetes after Bariatric SurgeryObesity Surgery, 2004
- Global Prevalence of DiabetesDiabetes Care, 2004
- Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes MellitusAnnals of Surgery, 2003
- The Disease Burden Associated With Overweight and ObesityJAMA, 1999
- The Prevention and Treatment of Obesity: Application to type 2 diabetesDiabetes Care, 1997
- Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.Cell Metabolism, 1983
- Variations in mortality by weight among 750,000 men and womenJournal of Chronic Diseases, 1979